|Bid||1,982.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1,971.30 - 2,007.55|
|52 Week Range||1,901.15 - 3,399.90|
|PE Ratio (TTM)||27.49|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Dr. Reddy's Laboratories Ltd.'s (RDY) first-quarter fiscal 2018 earnings per American Depositary Share (ADS) declined year over year while sales increased from the year ago quarter.
On a per-share basis, the Hyderabad, India-based company said it had net income of 6 cents. The pharmaceutical posted revenue of $513 million in the period. Doctor Reddy's shares have dropped 15 percent ...
India's big drugmakers will need at least five more years to improve their manufacturing standards and data reliability to a level demanded by international regulators, said a senior industry official. The lengthy timeline is a concern not only in India but around the world, as India's pharmaceutical firms supply a third of the drugs sold in the United States and a large percentage in other countries.